Telehealth Narcolepsy Prescribing: What Psychiatric NPs Can Do in Texas

If you’re a psychiatrist or PMHNP considering treating narcolepsy patients via telehealth, you’re probably asking yourself: Can I even prescribe these medications remotely? What’s legal in my state? And is this actually worth my time?

Good questions. Narcolepsy isn’t your typical psychiatric case — it’s a rare neurological condition affecting roughly 1 in 2,000 Americans, and managing it means prescribing controlled substances like stimulants and wakefulness agents through a maze of federal and state regulations. But here’s the reality: there’s massive unmet demand, telehealth has opened new doors, and if you understand the rules, narcolepsy medication management can be both clinically rewarding and economically solid.

Let’s break down what you can actually do, what varies by state, and how the business case stacks up.

The Federal Picture: DEA Flexibilities Extended (For Now)

The biggest question for any prescriber treating narcolepsy remotely: Can I prescribe Schedule II stimulants like Adderall or Ritalin without seeing the patient in person?

Short answer for 2026: Yes — but pay attention to timelines.

During COVID, the DEA suspended the Ryan Haight Act requirement for an initial in-person visit before prescribing controlled substances via telemedicine. That flexibility has been extended multiple times, most recently through December 31, 2025. This means you can initiate Schedule II–V prescriptions (think Adderall, modafinil, methylphenidate) after just a video consultation, no in-person exam required.

But here’s the catch: after 2025, all bets are off. The DEA and HHS are working on permanent telemedicine rules, and providers should prepare for potential new requirements — possibly including a special telemedicine registration or mandated in-person exams within 30 days of starting controlled substances. Stay alert to DEA announcements in late 2025.

Bottom line: Right now, tele-prescribing narcolepsy meds is legally straightforward at the federal level. Just make sure you’re using a DEA-compliant e-prescribing system and checking your state’s Prescription Drug Monitoring Program (PDMP) with every controlled substance script.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Psychiatrists vs PMHNPs: Who Can Prescribe What?

Psychiatrists (MD/DO): Full Authority, Minimal Restrictions

If you’re a board-certified psychiatrist, your scope is clear: you can diagnose narcolepsy, prescribe all medications (Schedule II stimulants, Schedule IV modafinil, sodium oxybate, antidepressants for cataplexy), and manage patients entirely via telehealth — as long as you’re licensed in the patient’s state.

No physician-specific prescribing restrictions exist for narcolepsy beyond standard controlled-substance compliance: maintain your DEA registration, check the PDMP, use electronic prescribing for controlled substances (EPCS), and document thoroughly. You’re treating this the same way you’d manage ADHD medication — frequent follow-ups, dose titration, side effect monitoring — just with a different indication.

State quirks to watch: A few states impose extra telehealth rules even for physicians. Florida, for example, technically prohibits prescribing Schedule II controlled substances via telehealth except for psychiatric disorders, inpatient settings, or hospice care. Since narcolepsy isn’t classified as a psychiatric disorder, a strict reading means you’d need at least one in-person visit in Florida. Practically, many providers use Schedule IV alternatives (modafinil) for tele-only care, or document comorbid conditions like ADHD to meet the psychiatric exception.

Most other states align with federal law — no additional physician barriers to tele-prescribing controlled substances as long as you establish a valid practitioner-patient relationship via video.

PMHNPs: It Depends Where You Practice

For psychiatric nurse practitioners, the story is more complicated. Your prescribing authority for narcolepsy medications hinges entirely on your state’s scope-of-practice laws.

Full-Practice States (Experienced NPs Function Like MDs):

• New York: After 3,600 hours of supervised practice (roughly 2 years), you no longer need a collaborative agreement. An experienced NY PMHNP can prescribe Schedule II–V narcolepsy medications independently, no physician oversight required.

• Illinois: Full Practice Authority kicks in after 4,000 hours + 250 hours of pharmacology CE. Illinois NPs can prescribe all narcolepsy meds independently, though there’s a quirk: if prescribing Schedule II narcotics (opioids), you need a monthly physician consultation documented. Stimulants aren’t subject to this rule, so managing narcolepsy with Adderall or modafinil is unrestricted for FPA-certified PMHNPs.

• California: AB 890 created a staged independence pathway. As of 2023, NPs can work as ‘103 NPs’ (in a physician-led group without individual supervision). By January 2026, those with 3+ years experience become ‘104 NPs’ — fully independent. Until then, you’ll need standardized procedures with a physician for Schedule II prescriptions, but experienced PMHNPs in CA can manage narcolepsy with minimal oversight by 2026.

Restricted-Practice States (You’ll Need Physician Collaboration):

• Texas: Texas mandates a Prescriptive Authority Agreement with a physician for all NP prescribing. Worse for narcolepsy: Texas law prohibits NPs from prescribing Schedule II drugs to outpatients except in hospital inpatient or hospice settings. That means you cannot independently prescribe Adderall or Ritalin for a narcolepsy patient in routine telehealth care. Your collaborating physician would have to write those scripts, or you’d stick to modafinil (Schedule IV, which you can prescribe with your PAA). Texas is frankly not NP-friendly for narcolepsy management.

• Florida: Florida APRNs can prescribe Schedule II substances, but only for a 7-day supply maximum — unless you’re a state-certified ‘psychiatric nurse’ prescribing psychiatric medications. Since narcolepsy isn’t a psychiatric disorder, technically you’re capped at 7 days per script, requiring weekly refills. That’s administratively brutal. Florida also doesn’t allow psychiatric NPs into its autonomous practice pathway (primary care NPs only), so you’ll need a supervising psychiatrist. Plus, Florida’s telehealth law prohibits Schedule II prescribing via telemedicine unless it’s for psychiatric treatment — creating a double bind. Many Florida PMHNPs rely on their collaborating MD to prescribe narcolepsy stimulants or use non-Schedule II alternatives.

• Pennsylvania: PA requires a collaborative agreement with a physician. You can prescribe Schedule II drugs, but only for a 30-day supply (90 days for Schedule III–IV). Monthly prescriptions align with good practice for stimulant management anyway, so this is workable — you’ll just need a physician partner on paper and must notify them within 24 hours of any Schedule II prescription.

Side-by-Side: Psychiatrist vs PMHNP Prescribing Authority by State

Key Takeaway: In progressive states (NY, IL, CA soon), PMHNPs with experience can manage narcolepsy nearly identically to psychiatrists. In restrictive states (TX, FL, PA), physician collaboration is mandatory and prescribing limits create extra hoops.

The Clinical Workflow: What Managing Narcolepsy Actually Looks Like

Narcolepsy medication management isn’t complicated, but it’s different from your typical psych med check. Here’s what you need to know:

Initial Evaluation:Most patients will come to you with a diagnosis already — usually from a sleep specialist after polysomnography and a Multiple Sleep Latency Test (MSLT). You’re not typically diagnosing narcolepsy from scratch via telehealth. Your job: verify the diagnosis (review sleep study reports), take a thorough history (excessive daytime sleepiness, cataplexy episodes, sleep paralysis), rule out mimickers (sleep apnea, depression causing hypersomnia), and establish baseline vitals if prescribing stimulants.

Medication Selection:

• First-line: Modafinil or armodafinil (Schedule IV wakefulness agents) — often tried first because they’re less controlled and have lower abuse potential.
• If insufficient: Amphetamine-based stimulants (Adderall, Vyvanse — Schedule II) or methylphenidate (Ritalin, Concerta — Schedule II). These require higher prescribing vigilance: monthly scripts, PDMP checks, monitoring for side effects like elevated blood pressure or insomnia.
• For cataplexy: Sodium oxybate (Xyrem/Xywav — Schedule III, highly regulated with a REMS program), or sometimes SSRIs/SNRIs off-label.

Most narcolepsy patients you’ll manage are on maintenance stimulant therapy — you’re not usually initiating brand-new treatments, but rather continuing prescriptions and optimizing doses.

Follow-Up Schedule:Expect monthly visits during titration, then every 3 months once stable. Federal Schedule II rules prohibit refills anyway, so monthly follow-ups for stimulants align with legal requirements. These are typically brief (15-20 minute) med checks: review symptom control (using tools like the Epworth Sleepiness Scale), check for side effects (BP, heart rate, weight, sleep quality at night), adjust dosing, refill prescriptions.

Administrative Reality:Narcolepsy meds often require prior authorization — especially newer agents like Sunosi (solriamfetol) or Wakix (pitolisant), and even modafinil. You’ll spend time documenting the diagnosis and justifying the prescription. Many insurers want proof you’ve tried first-line options before approving expensive alternatives. This is unpaid administrative work, but it’s part of the deal.

PDMP Checks:Every state requires (or strongly encourages) checking the Prescription Drug Monitoring Program before prescribing controlled substances. Some states mandate it every time (like New York), others require periodic checks. Budget 2-3 minutes per prescription to query the database and document your review.

Medication Shortages:Here’s a frustration you need to be ready for: the Adderall shortage that began in 2022 is still unresolved as of early 2024. Patients call panicked when their pharmacy can’t fill a script. You’ll need to be nimble — switching to alternative formulations (Vyvanse, methylphenidate), hunting for pharmacies with stock, or pivoting to non-Schedule II options. This adds unplanned touchpoints with patients and requires flexibility.

Telehealth-Specific Considerations:

• Video required: Audio-only won’t cut it for controlled substance prescribing in most states.
• State licensure: You must be licensed in every state where patients are located. No shortcuts.
• Local coordination: For labs (if checking liver function for certain meds) or BP monitoring, you’ll advise patients to use home devices or see a local PCP.
• Emergency protocols: Have a plan for adverse events (e.g., severe stimulant side effects). You can’t examine the patient in-person, so clear escalation pathways to local ERs are essential.

The Economics: Is This Worth Your Time?

Let’s talk money — because platform economics matter when you’re deciding whether to add narcolepsy to your practice.

Patient Demand:Narcolepsy is rare (roughly 160,000 diagnosed cases in the US), but it’s also severely underserved. Many patients can’t access sleep specialists (waitlists of 6+ months in some areas), and primary care providers are often uncomfortable managing controlled stimulants. Psychiatrists and PMHNPs who treat narcolepsy fill a critical gap, and patients are highly motivated — untreated narcolepsy is disabling (falling asleep while driving, losing jobs). Demand exists; the question is how you access it.

Reimbursement Rates:If billing insurance, narcolepsy med checks typically code as 99213 or 99214 (established patient E/M visits). Medicare allows roughly $80-$100 for 99213, $110-$130 for 99214. Private payers may reimburse $20-40 higher. Over a year of monthly visits during titration, then quarterly maintenance, one narcolepsy patient generates $1,000-$1,500 in annual revenue.

The catch: Mental health providers historically get paid about 22% less than other specialists by private insurers, a parity law violation that’s finally getting attention. Many psychiatrists opt out of insurance panels entirely. For narcolepsy, you can argue medical necessity under neurological codes (G47.4xx series), potentially sidestepping some behavioral health reimbursement issues — though results vary by payer.

Telehealth parity laws in states like California, New York, Illinois, and Pennsylvania ensure tele-visits are reimbursed at the same rate as in-person, which is crucial. Medicare also covers tele-mental health at parity through at least 2024-2025, though post-PHE rules may change.

NP reimbursement: If you’re a PMHNP, Medicare pays you at 85% of the physician fee schedule when billing under your own NPI. Some private insurers pay NPs equally, others follow Medicare’s model. Factor this into your income projections.

Cash-Pay Alternative:Given prior authorization headaches and reimbursement hassles, many telehealth providers operate on a cash-pay or subscription model. Narcolepsy patients, desperate for access, often pay out-of-pocket if it means getting timely care. A reasonable fee might be $150-$200 for an initial consult, $75-$125 for follow-ups. If you see 4-5 narcolepsy patients per month at those rates, you’re generating $3,000-$5,000 monthly — not bad for brief, focused med checks.

Platform vs. DIY Marketing:Here’s where the business case gets interesting. Acquiring psychiatric patients through DIY marketing (SEO, Google Ads, directory listings) is expensive and time-consuming. Realistic patient acquisition costs run $200-$500+ per booked patient when you factor in:

• Agency/consultant fees for SEO (6-12 months before meaningful traffic)
• Google Ads at $15-40+ per click in mental health keywords, with most clicks not converting
• Psychology Today or Zocdoc subscriptions ($100-300/month) plus per-booking fees ($35-100)
• Staff time to qualify leads and manage no-shows from cold traffic

Most solo practitioners don’t have the budget, expertise, or patience for this. A telehealth platform that delivers pre-qualified narcolepsy patients (already matched to your specialty and availability) removes the financial risk entirely. You pay only when patients book — no wasted ad spend, no upfront marketing investment, no gambling on campaigns that might fail.

Why This Matters for Narcolepsy:Narcolepsy patients are actively searching for providers who understand their condition and can prescribe the meds they need. They’re not browsing a directory of 500 local therapists hoping someone might help. They need a prescriber now. Platforms that connect these patients directly to qualified psychiatrists or PMHNPs create immediate ROI — you see patients, you get paid, you’re not spending months building a marketing funnel.

Compare that to spending $3,000-5,000/month on marketing with uncertain results. The platform model makes sense: guaranteed patient flow, no marketing overhead, predictable economics.

State-Specific Compliance: What You Must Know

Beyond scope-of-practice, each state has quirks that affect day-to-day narcolepsy prescribing:

California:

• Must check CURES (CA’s PDMP) before every controlled prescription
• E-prescribing mandatory for controlled substances
• Telehealth broadly permitted; no extra restrictions on controlled-substance tele-prescribing beyond federal law

Texas:

• Texas Medical Board requires telemedicine standard of care equivalent to in-person
• NPs need Prescriptive Authority Agreement filed with the Board
• PDMP (Texas PMP) checks required; pharmacists also verify
• Remember: NPs cannot prescribe Schedule II to outpatients — physician must handle those scripts

Florida:

• E-FORCSE (FL’s PDMP) check required before prescribing any controlled substance
• Telehealth Schedule II prohibition (unless psychiatric treatment or exceptions) — careful with narcolepsy since it’s not psych
• NP 7-day Schedule II limit creates weekly refill burden; collaborate with MD to manage
• Collaborative agreements for NPs must be in place and documented

New York:

• I-STOP PDMP check mandatory before every Schedule II–IV prescription
• E-prescribing required for all controlled substances
• Experienced NPs (3,600+ hours) practice independently; newer NPs need collaborative agreement on file
• No telehealth-specific controlled-substance restrictions beyond federal

Pennsylvania:

• PDMP check required for all controlled prescriptions
• NPs limited to 30-day Schedule II supply; must notify collaborating physician within 24 hours
• E-prescribing encouraged, not yet universally mandated for all controlled substances
• Collaborative agreements must cover specific drug categories NP will prescribe

Illinois:

• Illinois Prescription Monitoring Program (IL PMP) check required
• E-prescribing mandatory for controlled substances
• Full Practice Authority NPs have independent prescribing except opioid/benzo consultation rules (doesn’t affect narcolepsy stimulants)
• Newer NPs need collaborative agreement with explicit Schedule II delegation

Pro Tip: If you’re joining a telehealth platform, ask what compliance infrastructure they provide. Good platforms integrate PDMP lookups, maintain collaborative agreement templates for states that require them, and ensure e-prescribing systems are DEA-compliant. You shouldn’t be figuring this out solo.

Practical Challenges You’ll Face (And How to Handle Them)

Challenge #1: Confirming the DiagnosisYou’re not a sleep specialist. If a patient shows up without documented narcolepsy (no sleep study), you’re in a bind. Don’t wing it — refer them to a sleep center for proper testing. If they have a diagnosis, request copies of sleep study reports and specialist notes before prescribing.

Challenge #2: Prior AuthorizationsNarcolepsy meds require PAs more often than not. Budget admin time for this, or have support staff handle it if your platform offers that. Document the diagnosis thoroughly in your notes (including ICD-10 codes G47.411-G47.429) to streamline approvals.

Challenge #3: Medication ShortagesStay flexible. Have backup options ready (if Adderall is unavailable, switch to Vyvanse or methylphenidate; if modafinil is unaffordable, consider generic alternatives). Communicate proactively with patients about supply issues.

Challenge #4: Monitoring Side Effects RemotelyYou can’t check blood pressure in-person. Instruct patients to use home BP monitors and report readings. For weight or heart rate concerns, coordinate with their PCP or offer guidance on self-monitoring tools.

Challenge #5: Differentiating Narcolepsy from Other ConditionsSome patients have depression or sleep apnea causing daytime sleepiness, not narcolepsy. Take a thorough history. If uncertain, consult with or refer to a sleep specialist. Don’t prescribe stimulants without solid diagnostic footing — that’s both clinically inappropriate and a liability risk.

FAQ: Narcolepsy Prescribing via Telehealth

Can psychiatrists prescribe narcolepsy medications via telehealth?Yes. Psychiatrists (MD/DO) have full authority to prescribe all narcolepsy medications, including Schedule II stimulants, via telehealth as long as they’re licensed in the patient’s state and comply with federal controlled-substance rules. Current DEA flexibilities (through Dec 2025) allow initiating these prescriptions after a video visit without an in-person exam.

Can PMHNPs prescribe Adderall or Ritalin for narcolepsy?It depends on the state. In full-practice states like New York (after 3,600 hours) and Illinois (after 4,000 hours + CE), experienced PMHNPs can prescribe Schedule II stimulants independently. In restricted states like Texas, NPs cannot prescribe Schedule II to outpatients at all. In Florida and Pennsylvania, NPs can prescribe Schedule II but with significant limitations (7-day supply in FL, 30-day in PA) and required physician collaboration.

Do I need an in-person visit to prescribe narcolepsy medications via telehealth?Not currently, thanks to federal DEA flexibilities extended through December 2025. After that, new rules may apply — the DEA is working on permanent telemedicine regulations that could require in-person exams within a certain timeframe. Some states (like Florida) impose their own restrictions on telehealth prescribing of Schedule II drugs, which may require in-person visits depending on the indication.

How often do narcolepsy patients need follow-up visits?Typically monthly during initial titration and dose adjustments, then every 3 months once stable on medication. Federal law prohibits refills on Schedule II prescriptions, so patients on amphetamine-based stimulants will need monthly visits for new scripts anyway.

What’s the difference between modafinil and Adderall for narcolepsy?Modafinil (Schedule IV) is a wakefulness-promoting agent with lower abuse potential and is often tried first-line. It’s less controlled than Adderall, making prescribing simpler. Adderall (amphetamine, Schedule II) is a traditional stimulant that’s often more effective for severe narcolepsy but comes with higher regulation, abuse risk, and prescribing burdens (monthly scripts, stricter monitoring). Choice depends on patient response and prescriber/patient comfort with controlled substances.

What states allow PMHNPs to prescribe narcolepsy medications independently?States with full practice authority for experienced NPs include New York (after 3,600 hours), Illinois (after 4,000 hours + 250 CE hours), and California (by 2026 for ‘104 NPs’ with 3+ years experience). Other states like Pennsylvania, Texas, and Florida require ongoing physician collaboration and impose additional prescribing restrictions.

How do I handle prior authorizations for narcolepsy medications?Document the diagnosis thoroughly (include sleep study results, ICD-10 codes, prior treatment history). Many insurers require proof that first-line options (like modafinil) were tried before approving newer agents. Use your platform’s support staff if available, or allocate 30-60 minutes for PA paperwork per patient. It’s unpaid work, but necessary for patient access.

What should I do if my patient’s pharmacy can’t fill their stimulant prescription due to shortages?Have backup options ready. If Adderall is unavailable, switch to Vyvanse, methylphenidate, or dexmethylphenidate. Contact multiple pharmacies to find stock, or use telehealth-friendly mail-order pharmacies. Communicate transparently with patients about national supply issues — this has been an ongoing problem since 2022.

Do I need malpractice insurance that covers telehealth prescribing of controlled substances?Yes. Ensure your malpractice policy explicitly covers telemedicine and controlled substance prescribing. Follow evidence-based guidelines (confirm diagnosis, check PDMP, document informed consent, monitor side effects) to protect yourself. Most carriers have no issue with telehealth if you’re practicing within your scope and following standard of care.

How much can I earn managing narcolepsy patients via telehealth?Insurance reimbursement for med checks runs $80-$160 per visit depending on complexity and payer. One narcolepsy patient on maintenance therapy generates roughly $1,000-$1,500 annually through insurance billing. Cash-pay rates are typically $75-$200 per visit. If you manage 5-10 narcolepsy patients via a telehealth platform, that’s $5,000-$15,000 in annual revenue for a few hours of work per month.

Why This Matters: The Case for Joining a Telehealth Platform

If you’re a psychiatrist or PMHNP reading this, you’re probably weighing whether narcolepsy care via telehealth is a fit for your practice. Here’s the reality:

The demand is real. Narcolepsy patients are underserved, often unable to access sleep specialists, and desperately need providers who can prescribe their medications without a 6-month wait. You can fill that gap.

The regulations are manageable. Yes, there are hoops — PDMP checks, state licensing, collaborative agreements for NPs in some states, prior authorizations. But if you’re already managing ADHD or other controlled-substance prescribing, you know how to navigate this. The telehealth piece just adds convenience for patients (and you).

The economics work. Narcolepsy medication management involves brief, focused visits that can generate steady income through insurance reimbursement or cash-pay models. Compared to longer therapy sessions or complex med management for polypharmacy psych patients, narcolepsy care is straightforward and time-efficient. Monthly visits during titration, quarterly thereafter — predictable schedule, predictable revenue.

But here’s where platforms win: Trying to attract narcolepsy patients through DIY marketing is a losing game for most solo providers. You’d spend thousands on ads and months on SEO hoping to rank for ‘narcolepsy doctor near me’ searches, competing against established sleep centers and neurology groups. You’d pay $200-500 per patient lead (if you’re lucky), with no guarantee they’ll book or show up.

A telehealth platform flips that model. Patients come to the platform specifically searching for narcolepsy care. They’re pre-qualified, ready to book, and matched to your availability. You pay only when they see you — no upfront marketing spend, no wasted ad dollars, no months of ramp-up time. You get immediate patient flow, the platform handles compliance infrastructure (PDMP integrations, e-prescribing, collaborative agreement support), and you focus on what you’re trained to do: provide care.

For psychiatrists, this is a way to expand your scope beyond traditional mental health into a medically underserved niche without the overhead of building a separate practice.

For PMHNPs, especially in states with limited independent practice, platforms can facilitate the physician collaborations you need while giving you access to patients you’d never reach on your own.

Narcolepsy care isn’t the center of most psychiatric practices, but it’s a high-value add. The patients are loyal (they need ongoing medication management), the visits are efficient, the reimbursement is solid, and the clinical work is manageable. Join a platform that understands the regulatory complexities, delivers qualified patients, and lets you practice at the top of your license. That’s how you make this work — both for your patients and your bottom line.

Sources and Citations

1. Axios – ‘COVID-era telehealth prescribing extended again’ (Nov 18, 2024)
   https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall
   Federal DEA/HHS extension of telemedicine controlled-substance flexibilities through Dec 2025

2. Texas Medical Board – ‘Who can prescribe Schedule II drugs under physician delegation?’
   https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation
   Official guidance on Texas NP/PA Schedule II prescribing limitations (hospital/hospice only)

3. California Board of Registered Nursing – AB 890 NP Independence Implementation
   https://www.rn.ca.gov/practice/ab890.shtml
   Details on California’s 103/104 NP pathway and timeline (2023-2026)

4. Florida Senate – Chapter 464 Nursing Practice Act (2021 Statutes)
   https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All
   Florida’s 7-day Schedule II limit for APRNs and psychiatric nurse exemption

5. Rivkin Radler – ‘New Law Allows Experienced NPs to Practice Independently in NY’ (Apr 13, 2022)
   https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/
   Summary of NY’s permanent NP independence after 3,600 hours (2023 Budget law)

6. Pennsylvania Code – 49 Pa. Code §21.284 (CRNP Prescribing Limitations)
   https://www.pacodeandbulletin.gov/Display/pacode?file=/secure/pacode/data/049/chapter21/s21.284.html
   Official PA regulations on NP 30-day Schedule II and 90-day Schedule III-IV limits

7. Illinois General Assembly – 225 ILCS 65/ Nurse Practice Act (Full Practice Authority)
   https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act
   Illinois FPA requirements (4,000 hours + CE) and consultation rules for opioids/benzos

8. Medical Xpress / KFF Health News – ‘Narcolepsy patients face dual nightmare of medication shortages and stigma’ (Jan 3, 2024)
   https://medicalxpress.com/news/2024-01-patients-narcolepsy-dual-nightmare-medication.html
   Prevalence data (1 in 2,000), Adderall shortage impact on narcolepsy patients (2022-2024)

9. Axios San Antonio – ‘Texas churches address mental health access crisis’ (Aug 7, 2024)
   https://www.axios.com/local/san-antonio/2024/08/07/texas-churches-religion-mental-health-response
   Texas ranks last nationally in mental health access and workforce availability

10. Axios Chicago – ‘Illinois bill could make mental health care more affordable’ (Mar 6, 2025)
    https://www.axios.com/local/chicago/2025/03/06/illinois-mental-health-bill-reimbursement-rates
    Private insurers pay mental health providers 22% less than other physicians on average

11. Clinical Advisor – ‘Is Medicare’s 85% Reimbursement Rule Fair?’ (Feb 10, 2012)
    https://www.clinicaladvisor.com/home/the-waiting-room/is-medicares-85-reimbursement-rule-fair/
    Explanation of Medicare’s 85% payment rate for NP/PA services vs physician services

12. National Law Review – ‘New Florida Law Allows Telemedicine Prescribing of Controlled Substances’ (Apr 7, 2022)
    https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances
    Florida SB 312 analysis: Schedule III-V allowed via telehealth, Schedule II exceptions

13. New York State Education Department – NP Collaborative Practice FAQ
    https://www.op.nysed.gov/professions/nurse-practitioners/practice-issues/collaborative-practice-with-physicians
    Official NY guidance on collaborative agreements and practice protocols for NPs

14. Axios – ‘Biden’s mental health push faces workforce shortages, parity compliance issues’ (Aug 1, 2023)
    https://www.axios.com/2023/08/01/biden-mental-health-parity-behavioral-workforce-shortages
    Psychiatrist shortage projections (31,000 deficit by 2024), over 160M Americans in shortage areas

15. Axios Tampa Bay – ‘Florida nursing shortage persists despite recent improvements’ (Feb 2025)
    https://www.axios.com/newsletters/axios-tampa-bay-00660a40-ee01-11ef-add6-bdfcb630b18f

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20and,person%20doctor%27s%20visit%20for%20the
• https://natlawreview.com/article/new-florida-law-allows-telemedicine-prescribing-controlled-substances#:~:text=controlled%20substances%20via%20telemedicine%2C%20with,more%20on
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,drugs%2C%20such%20as
• https://www.ilga.gov/legislation/ILCS/details?ActID=1312&ActName=Nurse+Practice+Act.&ChapAct=225+ILCS+65%2F&Chapter=&ChapterID=24&MajorTopic=&Print=True&SeqEnd=17850000&SeqStart=16500000#:~:text=,require%20a%20physician%20name%3B
• https://www.rivkinrounds.com/2022/04/new-law-allows-experienced-nps-to-practice-independently-in-ny/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=%2A%20103%20NP%20,focus%20of%20their%20National%20Certification
• https://www.rn.ca.gov/practice/ab890.shtml#:~:text=Please%20note%2C%20the%20law%20requires,certify%20104%20NPs%20until%202026
• https://www.tmb.state.tx.us/274-who-can-prescribe-schedule-ii-drugs-under-physician-delegation#:~:text=1.%20in%20a%20hospital%20facility,has%20elected%20to%20receive%20hospice
• https://www.flsenate.gov/Laws/Statutes/2021/Chapter464/All#:~:text=match%20at%20L1566%20limit%20the,455
• https://www.pacodeandbulletin.gov/Display/pacode?file=%2Fsecure%2Fpacode%2Fdata%2F049%2Fchapter21%2Fs21.284.html#:~:text=,may%20not%20delegate%20prescriptive%20authority